DC09, Derivative of 3‐(2‐hydroxy‐5‐methoxyphenyl)‐1‐(5‐methylfuran‐2‐yl)prop‐2‐en‐1‐one Attenuates Nonalcoholic Fatty Liver Disease by Targeting PI3K/Akt Pathway: Insights From In‐Vivo Zebrafish Model and In‐Vitro HepG2 Cell

Documenti analoghi

• Evaluation of the antihypertensive and antihyperlipidaemic effects of a pyrimidine derivative in preventing cardiometabolic risk
  di: Baskar Aswinanand, et al.
  Pubblicazione: (2026)
• Advances in 3D Organoids and Organ‐on‐a‐Chip Systems for Biomedical Research
  di: Vignesh Sakthivel, et al.
  Pubblicazione: (2026)
• Marine‐Derived Molecular Glue Degraders: A New Frontier in Targeted Protein Degradation for Treatment of Multi‐Factorial Diseases
  di: Vajagathali Mohammed, et al.
  Pubblicazione: (2025)
• Combating Cadmium‐Induced Neurotoxicity, Oxidative Stress, and Inflammatory Pathways Using DOPA‐31, a Dioxopiperidinamide Derivative in an In Vivo Zebrafish Model
  di: Santhanam Sanjai Dharshan, et al.
  Pubblicazione: (2026)
• Therapeutic Potential of Methylindoline Derivative in Ameliorating Cadmium‐Induced Nephritis Experimented in Zebrafish Model
  di: S. P. Ramya Ranjan Nayak, et al.
  Pubblicazione: (2025)